| View HTML |
View PDF |
Section VII |
| 7.1a | Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1995 to 2004 |  (38 k) |
| Age |
| Blood Type |
| Residency |
| Gender |
| Race |
| Previous Transplant Same Organ |
| Time on Waiting List |
| 7.1b | Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active and Inactive Patient Comparison, 2000 to 2004 | (33 k) |
| Age |
| Gender |
| Race |
| Time on Waiting List |
| 7.2 | Time to Transplant, 1995 to 2004 New Pancreas After Kidney (PAK) Waiting List Registrations | (50 k) |
| Blood Type |
| Age |
| Gender |
| All Patient Types |
| Race |
| Residency |
| 7.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2004 Pancreas After Kidney (PAK) Waiting List | (40 k) |
| Age |
| Blood Type |
| Gender |
| Race |
| 7.4 | Transplant Recipient Characteristics, 1995 to 2004 Pancreas After Kidney (PAK) Recipients | (40 k) |
| Age |
| Blood Type |
| Residency |
| Gender |
| Race |
| Cold Ischemia Time |
| Hospitalized at Transplant |
| Previous Transplant Same Organ |
| Payment Source |
| 7.5 | Incidence of Transplant, 1995 to 2004 Pancreas After Kidney (PAK) Transplants per 1 Million Population | (29 k) |
| 7.6a | Immunosuppression Use for Induction, 1995 to 2004 Recipients with Pancreas After Kidney (PAK) Transplants | (30 k) |
| 7.6b | Immunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Pancreas After Kidney (PAK) Transplants | (32 k) |
| 7.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Pancreas After Kidney (PAK) Transplants | (29 k) |
| 7.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Pancreas After Kidney (PAK) Transplants | (30 k) |
| 7.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Pancreas After Kidney (PAK) Transplants | (31 k) |
| 7.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Pancreas After Kidney (PAK) Transplants | (31 k) |
| 7.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Pancreas After Kidney (PAK) Transplants | (32 k) |
| 7.6h | Persistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Pancreas After Kidney (PAK) Transplants | (34 k) |
| 7.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Pancreas After Kidney (PAK) Transplants | (30 k) |
| 7.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2003 Rates for Recipients during First Year after Pancreas After Kidney (PAK) Transplantation | (63 k) |
| Blood Type |
| Residency |
| Gender |
| Race |
| Age of Donor |
| Age |
| Cold Ischemia Time |
| Hospitalized at Transplant |
| Level of HLA Mismatch |
| 7.8 | Adjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (31 k) |
| Age |
| Gender |
| Race |
| 7.9 | Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (42 k) |
| Age |
| Blood Type |
| Residency |
| Gender |
| Race |
| Center Volume |
| Age of Donor |
| Cold Ischemia Time |
| Hospitalized at Transplant |
| Level of HLA Mismatch |
| 7.10 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Pancreas After Kidney (PAK) Transplants | (29 k) |
| 7.11 | Adjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (31 k) |
| Age |
| Gender |
| Race |
| 7.12 | Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (41 k) |
| Age |
| Blood Type |
| Residency |
| Gender |
| Race |
| Center Volume |
| Age of Donor |
| Cold Ischemia Time |
| Hospitalized at Transplant |
| Level of HLA Mismatch |
| 7.13 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Pancreas After Kidney (PAK) Transplants | (29 k) |
| 7.14 | Prevalence of People Living with a Functioning Transplant at End of Year Pancreas After Kidney (PAK) Recipients, 1995 to 2004 | (37 k) |
| Blood Type |
| Residency |
| Gender |
| Race |
| Age |
| Hospitalized at Transplant |
| Previous Transplant Same Organ |
| 7.15 | Transplants by State and Transplant Center, 1995 to 2004 Pancreas After Kidney (PAK) | (63 k) |